NCT02423603 2025-03-10
PAKT
Queen Mary University of London
Phase 2 Completed
Clinical Trials
7 trialsNCT02338622 2024-09-26
ComPAKT
Royal Marsden NHS Foundation Trust
Phase 1 Completed
NCT02117167 2024-01-10
SAFIR02_Lung
UNICANCER
Phase 2 Completed
NCT03310541 2023-05-06
AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02121639 2022-05-05
ProCAID
University Hospital Southampton NHS Foundation Trust
Phase 1/2 Completed
NCT02451956 2019-12-30
Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy
Samsung Medical Center
Phase 2 Completed
NCT02077569 2017-05-04
STAKT
University of Nottingham
Phase 2 Completed